AU2633288A - Intercellular adhesion molecules and their binding ligands - Google Patents

Intercellular adhesion molecules and their binding ligands

Info

Publication number
AU2633288A
AU2633288A AU26332/88A AU2633288A AU2633288A AU 2633288 A AU2633288 A AU 2633288A AU 26332/88 A AU26332/88 A AU 26332/88A AU 2633288 A AU2633288 A AU 2633288A AU 2633288 A AU2633288 A AU 2633288A
Authority
AU
Australia
Prior art keywords
adhesion molecules
intercellular adhesion
binding ligands
ligands
intercellular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU26332/88A
Other versions
AU629189B2 (en
Inventor
Michael L. Dustin
Steven D. Marlin
Robert Rothlein
Timothy A. Springer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dana Farber Cancer Institute Inc
Original Assignee
Dana Farber Cancer Institute Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dana Farber Cancer Institute Inc filed Critical Dana Farber Cancer Institute Inc
Priority to AU26332/88A priority Critical patent/AU629189B2/en
Publication of AU2633288A publication Critical patent/AU2633288A/en
Application granted granted Critical
Publication of AU629189B2 publication Critical patent/AU629189B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2821—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against ICAM molecules, e.g. CD50, CD54, CD102
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70525—ICAM molecules, e.g. CD50, CD54, CD102
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2845—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/5743—Specifically defined cancers of skin, e.g. melanoma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU26332/88A 1987-05-04 1988-11-29 Intercellular adhesion molecules and their binding ligands Expired AU629189B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU26332/88A AU629189B2 (en) 1987-05-04 1988-11-29 Intercellular adhesion molecules and their binding ligands

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US4596387A 1987-05-04 1987-05-04
US045963 1987-05-04
US115798 1987-11-01
US11579887A 1987-11-02 1987-11-02
US15594388A 1988-02-16 1988-02-16
US155943 1988-02-16
AU26332/88A AU629189B2 (en) 1987-05-04 1988-11-29 Intercellular adhesion molecules and their binding ligands

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU15518/88A Division AU1551888A (en) 1987-05-04 1988-05-03 Intercellular adhesion molecules and their binding ligands

Publications (2)

Publication Number Publication Date
AU2633288A true AU2633288A (en) 1989-05-18
AU629189B2 AU629189B2 (en) 1992-10-01

Family

ID=27422820

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26332/88A Expired AU629189B2 (en) 1987-05-04 1988-11-29 Intercellular adhesion molecules and their binding ligands

Country Status (1)

Country Link
AU (1) AU629189B2 (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991018011A1 (en) * 1990-05-15 1991-11-28 Swinburne Limited Inhibition of cell adhesion using intercellular adhesion molecule-1-like peptides and/or analogues thereof
WO1991018010A1 (en) * 1990-05-15 1991-11-28 Swinburne Limited Inhibition of viral infection using intercellular adhesion molecule-1-like peptides and/or analogues thereof
US6051231A (en) * 1988-09-01 2000-04-18 Bayer Corporation Antiviral methods and prepations
US6096862A (en) * 1990-07-20 2000-08-01 Bayer Corporation Multimeric antiviral agent
US6107461A (en) * 1990-07-20 2000-08-22 Bayer Corporation Multimeric forms of human rhinovirus receptor and fragments thereof, and method of use
US6130202A (en) * 1990-07-20 2000-10-10 Bayer Corporation Antiviral methods
US6143298A (en) * 1988-09-01 2000-11-07 Bayer Corporation Soluble truncated forms of ICAM-1
US6326004B1 (en) 1988-09-01 2001-12-04 Bayer Corporation Antiviral methods using fragments of human rhinovirus receptor (ICAM-1)
US7132395B1 (en) 1988-09-01 2006-11-07 Bayer Pharmaceuticals Corporation Antiviral methods using human rhinovirus receptor (ICAM-1)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2011633C (en) * 1989-03-09 2007-05-15 Timothy A. Springer Intercellular adhesion molecule - 2 and its binding ligands
HU217792B (en) * 1989-03-16 2000-04-28 Dana Farber Cancer Institute Method for preparing intercellular adhesion molecule (icam-1) and pharmaceutical compositions containing them

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6051231A (en) * 1988-09-01 2000-04-18 Bayer Corporation Antiviral methods and prepations
US6143298A (en) * 1988-09-01 2000-11-07 Bayer Corporation Soluble truncated forms of ICAM-1
US6326004B1 (en) 1988-09-01 2001-12-04 Bayer Corporation Antiviral methods using fragments of human rhinovirus receptor (ICAM-1)
US6514936B1 (en) 1988-09-01 2003-02-04 Bayer Corporation Antiviral methods using human rhinovirus receptor (ICAM-1)
US7132395B1 (en) 1988-09-01 2006-11-07 Bayer Pharmaceuticals Corporation Antiviral methods using human rhinovirus receptor (ICAM-1)
WO1991018011A1 (en) * 1990-05-15 1991-11-28 Swinburne Limited Inhibition of cell adhesion using intercellular adhesion molecule-1-like peptides and/or analogues thereof
WO1991018010A1 (en) * 1990-05-15 1991-11-28 Swinburne Limited Inhibition of viral infection using intercellular adhesion molecule-1-like peptides and/or analogues thereof
US6096862A (en) * 1990-07-20 2000-08-01 Bayer Corporation Multimeric antiviral agent
US6107461A (en) * 1990-07-20 2000-08-22 Bayer Corporation Multimeric forms of human rhinovirus receptor and fragments thereof, and method of use
US6130202A (en) * 1990-07-20 2000-10-10 Bayer Corporation Antiviral methods

Also Published As

Publication number Publication date
AU629189B2 (en) 1992-10-01

Similar Documents

Publication Publication Date Title
AU6319294A (en) Intercellular adhesion molecules, and their binding ligands
ZA924276B (en) Intercellular adhesion molecule-3 and its binding ligands
AU606683B2 (en) Foam-fiber composite and process
AU2709588A (en) Chromatographic binding assay devices and methods
AU5993586A (en) Improvements in filters
AU572756B2 (en) Book binding process
AU562504B2 (en) Polysuccinimides and complexes with proteins
AU7804287A (en) Bookcover and binding method
AU2633288A (en) Intercellular adhesion molecules and their binding ligands
AU4213285A (en) Improvements in and relating to perfect binding
AU2370188A (en) Supercharger
AU647382B2 (en) Intercellular adhesion molecules and their binding ligands
EP0295095A3 (en) Bookbinding and its products
GB8816401D0 (en) Book binding
AU1901088A (en) Container and dispensing-closure assembly
AU2763692A (en) Use of intercellular adhesion molecules, and their binding ligands in the treatment of asthma
ZA883159B (en) Intercellular adhesion molecules and their binding ligands
AU5904786A (en) Improvements in hinges
ZA897335B (en) Intercellular adhesion molecules and their binding ligands
AU549562B2 (en) Binding elongate products
IE960275L (en) Intercellular adhesion molecules, and their binding ligands
GB2173449B (en) Binding method and booklet
AU3739089A (en) Binder spine assembly
AU2687684A (en) Cheque and/or deposit books
AU549443B3 (en) Improvements in hinges